OCU sends out notice after Munharo weight loss drug arrives in Spain
It arrived in pharmacies this Monday. Mujaroa related drug to Ozempic and Wegovy, indicated for type 2 diabetes and obesity. This is due to tirzepatidean active ingredient that “boosts” the results and improves them compared to existing antidotes. However, despite the many benefits, the Organization of Consumers and Users (OCU) has sent out a notice to all people who want to become one.
Mujaro is approved for two indications: diabetes type 2 – which affects one in seven adults in Spain, the second highest rate in Europe – and for weight control in people with a body mass index (BMI) greater than 27 and at least one complication caused by overweight or obesity – BMI greater than 30–.
This is a new drug because, due to its mechanism of action, in addition to promote glycemic control, It reduces appetite, increases satiety and reduces excess fat. This is the reason, among other things, for the patient’s weight loss.
New drug It is not funded by the state system. This is because tirzepatide, despite its effectiveness, is an active substance that can only be used with a prescription and the exclusive recommendation of a doctor, so it cannot be ordered for free at a pharmacy. Thus, the PCU has notified all people, pharmacists are obliged sell it to the patient who really needs it. Otherwise, it may have side effects.
In this sense, in Spain these drugs, in their weight-loss version, are not financed by the health system. Therefore, the OCU reports, the patient must pay the full cost of treatment, which amounts to 271 euros per month for treatment with five milligrams, and in the case of treatment with 10 milligrams the cost increases to 358 euros.
What are the side effects?
He Ozempic and Vegovy They were used incorrectly to lose a few kilos. For this reason, Mar Malagon, president of the Spanish Society for the Fight against Obesity, assured during the presentation of the drug that if they are not necessary, “it will not do you any good”, because changing the entire hormonal system can cause “long-term harmful effects. “term”.
In addition, one of its side effects is muscle loss, which must be mitigated by exercise, although the weight loss is three times greater. Others act mildly and are very similar to the effects of semaglutide, such as: nausea, diarrhea and vomiting. Only 4.2% of patients had to leave the hospital. care.